WT1 and familial pancreatic carcinoma: A phase I trial to investigated the safety and efficacy following treatment with DCs pulsed with a mixture of three types of WT1 peptides in combination with chemotherapy in pancreatic cancer and intrahepatic cholangiocarcinoma.